Singulex, Inc

Singulex pioneered technology that can quantitatively detect single molecules such as proteins and metabolites in complex biological samples. Our patented technology extends the dynamic range of any immunoassay by orders of magnitude, allowing drug developers to use biomarkers to measure drug efficacy, safety and disease progression. In addition, our technology is applicable to the diagnostics market, and we are actively pursuing the development of diagnostics that will change the face of medicine.
>
We have leveraged this unique technology to develop the Erenna™ Technology Access Program (ETAP) that allows select pharmaceutical companies to partner with us and to access our menu of biomarker immunoassays, sample analysis and just-in-time customized assay development services as well as our world-class Erenna Immunoassay System.

Contact Details: 1650 Harbor Bay Pkwy Suite 200 Alameda CA 94502 United States of America Tel: (510) 814-9000 Fax: (510) 814-9018 Email: d.hagebush@singulex.com WWW: www.singulex.com/

Loading...

Press Releases on Singulex, Inc:
Frost & Sullivan Recognizes Singulex for Erenna(R) Immunoassay System	15th June, 2009	Frost & Sullivan	Enabling High Resolution Monitoring of Drug Efficacy and Safety MOUNTAIN VIEW, Calif., June 15 /PRNewswire/ -- Based on its recent analysis in the area of immunoassay technologies for biomarker
Singulex Closes $19 Million Financing Round	12th January, 2009	Singulex, Inc.	ALAMEDA, Calif., Jan. 12 /PRNewswire/ -- Singulex, Inc. today announced that it has closed a $19 million financing round, led by JAFCO Co., Ltd. and supported by existing investors including OrbiMed
Singulex to Develop Assays to Assess Efficacy of Cancer Therapeutics	29th July, 2008	Singulex Inc.	ALAMEDA, Calif., July 29 /PRNewswire/ -- Singulex Inc. today announced that it secured the second phase of its Fast Track Small Business Innovation Research (SBIR) contract from the National

BioNews Results for Singulex, Inc:
PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis AG, FedEx Corp., Google Inc., Me	Guru Focus:  Nov 22 2009 3:56PM Matching: inc
Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Cogent Inc, AMERICAN PUBLIC EDUCATION, INC, Whitne	Guru Focus:  Nov 22 2009 5:13PM Matching: inc
N.J. index reaches a yearly high	Asbury Park Press:  Nov 22 2009 12:49PM Matching: inc
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.	Individual.com:  Nov 21 2009 6:41AM Matching: inc
Stocks That Stand Out For Nov. 20th, 2009 Are ARTS, RFMD, CLDS, ACTC	Pharmacy Choice:  Nov 21 2009 1:27PM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Singulex, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 267 times since April 2007, the link to the organisation's website has been followed 32 times

Recent Search Terms used to find this page: singulex technology | Business reports on Singulex | singulex inc. | singulex | Cost of Erenna Immunoassay System | SINGULEX PRICE LIST | singulex | singulex | .

Search for more companies in Alameda

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Singulex, Inc